Results 131 to 140 of about 2,795 (144)

Elexacaftor-Tezacaftor-Ivacaftor as a Final Frontier in the Treatment of Cystic Fibrosis: Definition of the Clinical and Microbiological Implications in a Case-Control Study

Pharmaceuticals, 2022
Dafne Bongiorno, Stefania Stefani, Francesca di Bernardo   +2 more
exaly  

Ivacaftor/lumacaftor/tezacaftor

Reactions Weekly, 2019
openaire   +1 more source

Therapeutic Drug Monitoring of Ivacaftor, Lumacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis: Where Are We Now?

Pharmaceutics, 2022
Eva Choong, Laurent Decosterd, Sylvain Blanchon   +2 more
exaly  

Tezacaftor and ivacaftor for the treatment of cystic fibrosis

Expert Review of Respiratory Medicine, 2020
Peter Barry, Alex Horsley
exaly  

Elexacaftor/Ivacaftor/tezacaftor/Ivacaftor/tezacaftor

Reactions Weekly
openaire   +1 more source

Ivacaftor/tezacaftor

Reactions Weekly
openaire   +1 more source

No drug-drug interaction between tezacaftor-ivacaftor and clofazimine: A case report

Journal of Cystic Fibrosis, 2022
exaly  

Elexacaftor/tezacaftor/ivacaftor

Reactions Weekly
openaire   +1 more source

The preclinical discovery and development of the combination of ivacaftor + tezacaftor used to treat cystic fibrosis

Expert Opinion on Drug Discovery, 2020
Maria Favia, Sante Di Gioia, Onofrio Laselva   +2 more
exaly  

Patent Review of Synthetic Routes and Crystalline Forms of the CFTR-Modulator Drugs Ivacaftor, Lumacaftor, Tezacaftor, and Elexacaftor

Organic Process Research and Development, 2019
David Hughes
exaly